Total trials
307
Active
62
Phase 3
2
Total enrollment
55,514
Pipeline matrix
Showing 7 of 7 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Lu-177 PSMA-617 | — | — | — | — | — | 1 | |
| Terbium 161- PSMA I&T | — | — | — | — | — | 1 | |
| Preemptive Multimodal Intravenous Analgesia | — | — | — | — | — | 1 | |
| bioceramic based intracanal medication | — | — | — | — | — | 1 | |
| Calcium Hydroxide Intracanal medication | — | — | — | — | — | 1 | |
| Chemotherapy | — | — | — | — | — | 1 | |
| İNTRATECHAL MORPHİNE GROUP | — | — | — | — | — | 1 |
Next readouts
- 2024-11-30
- 2025-05-30
- 2025-11-25
- 2026-04-15
- 2028-02-01
- 2028-08-01
Top conditions
- Stroke7
- Pain6
- Postoperative Pain6
- Acute Kidney Injury5
- Anxiety5
- Anesthesia5
- Parkinson Disease5
- Breast Cancer4
Frequently asked questions about Ankara University
- How many clinical trials does Ankara University have on ClinicalTrials.gov?
- Ankara University is listed as the lead sponsor on 307 clinical trials in ClinicalTrials.gov, 62 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Ankara University's trials are in Phase 3?
- 2 of Ankara University's trials are in Phase 3, spread across 7 active drug programs.
- What therapeutic areas does Ankara University focus on?
- Ankara University's most-studied conditions on ClinicalTrials.gov are Stroke, Pain, Postoperative Pain, Acute Kidney Injury, Anxiety.
- When are Ankara University's next clinical trial readouts?
- Ankara University has 6 upcoming primary-completion readouts tracked here; the soonest is “The Effect of Intrathecal Morphine and Erector Spina Plan Block on Serum Cytokine Levels and Chronic Pain in Caesarean Section Surgery”, expected around 2024-11-30.